Aleph Farms' unique non-GMO technology relies on a natural process occurring in cows to regenerate and build muscle tissues.
Aleph Farms Ltd., Israel, raised $12 million in series A investments from a blend of classic venture capitalists and strategic partners, and led by VisVires New Protein (VVNP), Singapore, with Cargill Protein, Wichita, Kan., and M-Industry, Migros, Switzerland, as new investors. Existing investors also joining this round include Strauss Group, Israel; Peregrine Ventures, Israel; CPT Capital, UK; Jesselson investments, Israel; New Crop Capital, San Francisco; and Technion Investment Opportunity Fund, Israel.
Aleph Farms' unique non-GMO technology relies on a natural process occurring in cows to regenerate and build muscle tissues.